Elequin Capital LP Liva Nova PLC Transaction History

Elequin Capital LP

$137 Million
Q3 2024

A detailed history of Elequin Capital LP transactions in Liva Nova PLC stock. As of the latest transaction made, Elequin Capital LP holds 249 shares of LIVN stock, worth $13,067. This represents 0.01% of its overall portfolio holdings.

Number of Shares

249

Holding current value

$13,067

% of portfolio

0.01%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$43.38 - $54.59 $10,801 - $13,592	249 New	249 $13,000
Q4 2023 Feb 14, 2024	SELL	$43.45 - $53.66 $173 - $214	-4 Reduced 40.0%	6 $0
Q3 2023 Nov 14, 2023	SELL	$50.12 - $58.87 $9,973 - $11,715	-199 Reduced 95.22%	10 $0
Q2 2023 Aug 14, 2023	BUY	$42.28 - $51.43 $8,836 - $10,748	209 New	209 $10,000
Q4 2022 Feb 09, 2023	BUY	$43.88 - $56.16 $526 - $673	12 New	12 $0
Q3 2022 Nov 10, 2022	SELL	$48.37 - $66.5 $725 - $997	-15 Reduced 55.56%	12 $1,000
Q2 2022 Aug 11, 2022	SELL	$57.25 - $86.63 $171 - $259	-3 Reduced 10.0%	27 $2,000
Q1 2022 May 16, 2022	BUY	$71.02 - $86.99 $2,130 - $2,609	30 New	30 $2,000

Others Institutions Holding LIVN

# of Institutions

262

Shares Held

53M

Call Options Held

316K

Put Options Held

127K

Black Rock Inc. New York, NY

6.9M
Shares

$362 Million
0.01% of portfolio
Primecap Management CO Pasadena, CA

5.63M
Shares

$295 Million
0.22% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

2.96M
Shares

$155 Million
0.08% of portfolio
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct

2.09M
Shares

$110 Million
0.3% of portfolio
Vanguard Group Inc Valley Forge, PA

2.08M
Shares

$109 Million
0.0% of portfolio

View Full List

About LivaNova PLC

Ticker LIVN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,545,700
Market Cap $2.81B
Description
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...

More about LIVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Elequin Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Elequin Capital LP with notifications on news.

Account